title: [PD-1 Antibodies. A new therapeutic option for metastatic malignant melanoma].
authors.affiliation: Klinik und Poliklinik für Dermatologie, Universität Regensburg, Franz-Josef-Strauss-Allee 11, 93053, Regensburg, Deutschland. christian.hafner@ukr.de
authors.forename: C
authors.initials: C
authors.lastname: Hafner
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis* / Q000276:immunology; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology / Q000556:secondary*; D000077594:Nivolumab; D061026:Programmed Cell Death 1 Receptor / Q000032:analysis* / Q000276:immunology; D012878:Skin Neoplasms / Q000737:chemistry* / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D000077594:Nivolumab